Product Description
a single use, temporary intraluminal bypass device,intended to reduce contact of fecal content with an anastomotic site, following colorectal surgery (open or laparoscopic). (Sourced from: https://clinicaltrials.gov/ct2/show/NCT03352570)
Mechanisms of Action: Device
Novel Mechanism: No
Modality: Device
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: India
Approved Indications: None
Known Adverse Events: None
Company: SafeHeal
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic: